TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE (USD BILLION)
6.1. Dry Age-Related Macular Degeneration
6.2. Wet Age-Related Macular Degeneration
6.3. Geographic Atrophy
7. AGE-RELATED MACULAR DEGENERATION MARKET, BY TREATMENT METHOD (USD BILLION)
7.1. Anti-VEGF Therapy
7.2. Photodynamic Therapy
7.3. Laser Surgery
7.4. Nutritional Supplements
8. AGE-RELATED MACULAR DEGENERATION MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
8.1. Hospitals
8.2. Optical Clinics
8.3. Retail Pharmacies
8.4. Online Pharmacies
9. AGE-RELATED MACULAR DEGENERATION MARKET, BY PATIENT DEMOGRAPHICS (USD BILLION)
9.1. Elderly Patients
9.2. Middle-Aged Patients
9.3. Genetic Predisposition
10. AGE-RELATED MACULAR DEGENERATION MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Age-Related Macular Degeneration Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Age-Related Macular Degeneration Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Eyenuk
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Pfizer
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Apellis Pharmaceuticals
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Horizon Therapeutics
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Iveric Bio
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Roche
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. EyePoint Pharmaceuticals
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. KAZIA Therapeutics
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Oxurion
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Santen Pharmaceutical
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Novartis
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Regeneron Pharmaceuticals
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Graybug Vision
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Bayer
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Allergan
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 8. US AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 9. US AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 10. US AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 11. US AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 28. UK AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 29. UK AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 30. UK AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 31. UK AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 58. APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 59. APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 60. APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 61. APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 75. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 76. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 78. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 79. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 80. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 81. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 83. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 84. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 85. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 86. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 88. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 89. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 90. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 91. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 93. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 94. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 95. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 96. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 98. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 99. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 100. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 101. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102. SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 103. SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 104. SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 105. SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 106. SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 108. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 109. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 110. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 111. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 113. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 114. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 115. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 116. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 118. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 119. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 120. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 121. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127. MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 128. MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 129. MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 130. MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 131. MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 133. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 134. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 135. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 136. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 138. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 139. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 140. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 141. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 143. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT METHOD, 2019-2035 (USD BILLIONS)
TABLE 144. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 145. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2035 (USD BILLIONS)
TABLE 146. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS
FIGURE 3. US AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 4. US AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 5. US AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 6. US AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 7. US AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 9. CANADA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 10. CANADA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 11. CANADA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 12. CANADA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS
FIGURE 14. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 15. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 16. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 17. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 18. GERMANY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 20. UK AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 21. UK AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 22. UK AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 23. UK AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 25. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 26. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 27. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 28. FRANCE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 30. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 31. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 32. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 33. RUSSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 35. ITALY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 36. ITALY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 37. ITALY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 38. ITALY AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 40. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 41. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 42. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 43. SPAIN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 45. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 46. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 47. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 48. REST OF EUROPE AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS
FIGURE 50. CHINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 51. CHINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 52. CHINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 53. CHINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 54. CHINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 56. INDIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 57. INDIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 58. INDIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 59. INDIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 61. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 62. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 63. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 64. JAPAN AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 66. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 67. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 68. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 69. SOUTH KOREA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 71. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 72. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 73. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 74. MALAYSIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 76. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 77. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 78. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 79. THAILAND AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 81. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 82. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 83. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 84. INDONESIA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 86. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 87. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 88. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 89. REST OF APAC AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS
FIGURE 91. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 92. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 93. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 94. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 95. BRAZIL AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 97. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 98. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 99. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 100. MEXICO AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 102. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 103. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 104. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 105. ARGENTINA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 107. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 108. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 109. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 110. REST OF SOUTH AMERICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 113. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 114. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 115. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 116. GCC COUNTRIES AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 118. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 119. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 120. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 121. SOUTH AFRICA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TYPE
FIGURE 123. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY TREATMENT METHOD
FIGURE 124. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 125. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
FIGURE 126. REST OF MEA AGE-RELATED MACULAR DEGENERATION MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF AGE-RELATED MACULAR DEGENERATION MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF AGE-RELATED MACULAR DEGENERATION MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: AGE-RELATED MACULAR DEGENERATION MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: AGE-RELATED MACULAR DEGENERATION MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: AGE-RELATED MACULAR DEGENERATION MARKET
FIGURE 133. AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2025 (% SHARE)
FIGURE 134. AGE-RELATED MACULAR DEGENERATION MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
FIGURE 135. AGE-RELATED MACULAR DEGENERATION MARKET, BY TREATMENT METHOD, 2025 (% SHARE)
FIGURE 136. AGE-RELATED MACULAR DEGENERATION MARKET, BY TREATMENT METHOD, 2019 TO 2035 (USD Billions)
FIGURE 137. AGE-RELATED MACULAR DEGENERATION MARKET, BY DISTRIBUTION CHANNEL, 2025 (% SHARE)
FIGURE 138. AGE-RELATED MACULAR DEGENERATION MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)
FIGURE 139. AGE-RELATED MACULAR DEGENERATION MARKET, BY PATIENT DEMOGRAPHICS, 2025 (% SHARE)
FIGURE 140. AGE-RELATED MACULAR DEGENERATION MARKET, BY PATIENT DEMOGRAPHICS, 2019 TO 2035 (USD Billions)
FIGURE 141. AGE-RELATED MACULAR DEGENERATION MARKET, BY REGIONAL, 2025 (% SHARE)
FIGURE 142. AGE-RELATED MACULAR DEGENERATION MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
